Myostatin inhibition using mRK35 produces skeletal muscle growth and tubular aggregate formation in wild type and TgACTA1D286G nemaline myopathy mice

MLA

Zizhao Zhang, et al. Myostatin Inhibition Using MRK35 Produces Skeletal Muscle Growth and Tubular Aggregate Formation in Wild Type and TgACTA1D286G Nemaline Myopathy Mice. Feb. 2018. EBSCOhost, https://doi.org/10.1093/hmg/ddx431.

APA

Zizhao Zhang, Hui Meng, Jane Owens, Jennifer Tinklenberg, Nigel G. Laing, Margaret Beatka, Emily M. Siebers, Carl Morris, Kristen J. Nowak, Jacob A. Ross, Lin Yang, Julien Ochala, & Michael W. Lawlor. (2018). Myostatin inhibition using mRK35 produces skeletal muscle growth and tubular aggregate formation in wild type and TgACTA1D286G nemaline myopathy mice. https://doi.org/10.1093/hmg/ddx431

Chicago

Zizhao Zhang, Hui Meng, Jane Owens, Jennifer Tinklenberg, Nigel G. Laing, Margaret Beatka, Emily M. Siebers, et al. 2018. “Myostatin Inhibition Using MRK35 Produces Skeletal Muscle Growth and Tubular Aggregate Formation in Wild Type and TgACTA1D286G Nemaline Myopathy Mice,” February. doi:10.1093/hmg/ddx431.